Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person GCC2(1-1204)-ALK(1059-1620) fusion [cytosol]

Class:Id	EntityWithAccessionedSequence:9713458
_displayName	GCC2(1-1204)-ALK(1059-1620) fusion [cytosol]
_timestamp	2021-01-26 00:55:51
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9713461] Rothfels, Karen, 2021-01-26
disease	[Disease:1247848] non-small cell lung carcinoma
endCoordinate	1204
hasModifiedResidue	[FragmentInsertionModification:9713431] Insertion of residues 1059 to 1620 at 1205 from UniProt:Q9UM73 ALK
literatureReference	[LiteratureReference:9713384] Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
name	GCC2(1-1204)-ALK(1059-1620) fusion GRIP and coiled-coil domain-containing protein 2 GCC2_HUMAN
referenceEntity	[ReferenceGeneProduct:91143] UniProt:Q8IWJ2 GCC2 [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9713464] R-HSA-9713458.1
startCoordinate	1
(hasCandidate)	[CandidateSet:9700080] ALK fusion proteins [cytosol] [Homo sapiens]
(hasComponent)	[Complex:9713491] GCC2(1-1204)-ALK(1059-1620) fusion dimer [cytosol] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by GCC2(1-1204)-ALK(1059-1620) fusion [cytosol] (9713458)